TEVA | Teva Pharmaceutical Industries Limited Stock Financials Income Statements Annual

(Stock Exchange: NYSE)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31
Revenue	15.85B	14.93B	15.88B	16.66B	16.89B	18.85B	22.39B	21.90B	19.65B	20.27B	20.31B	20.32B	18.31B	16.12B	13.90B	11.09B	9.41B	8.41B	5.25B	4.80B	3.28B	2.52B	2.08B	1.75B	1.28B	1.12B	1.12B	953.80M	667.70M	587.70M
Cost of Revenue	8.20B	7.95B	8.28B	8.93B	9.35B	10.56B	11.56B	10.04B	8.30B	9.22B	9.61B	9.66B	8.80B	7.06B	6.53B	5.12B	4.53B	4.15B	2.77B	2.56B	1.76B	1.42B	1.23B	962.99M	699.20M	636.10M	628.90M	550.40M	364.10M	305.70M
Gross Profit	7.65B	6.97B	7.59B	7.72B	7.54B	8.30B	10.82B	11.86B	11.36B	11.06B	10.71B	10.65B	9.52B	9.06B	7.37B	5.97B	4.88B	4.26B	2.48B	2.24B	1.52B	1.10B	847.29M	786.86M	583.20M	479.80M	488.00M	403.40M	303.60M	282.00M
Operating Expenses	4.45B	4.28B	4.50B	4.67B	4.82B	5.43B	6.83B	7.21B	6.24B	6.57B	6.75B	6.47B	5.50B	4.77B	4.30B	4.82B	2.48B	2.16B	1.17B	1.06B	634.10M	571.40M	470.84M	411.65M	384.16M	334.80M	314.20M	274.10M	188.40M	175.30M
Selling, General & Admin	3.50B	3.44B	3.53B	3.67B	3.81B	4.21B	4.99B	5.10B	4.72B	5.08B	5.32B	5.12B	4.41B	3.83B	3.50B	2.51B	1.90B	1.57B	798.80M	696.50M	520.60M	406.40M	363.56M	307.08M	233.89M	208.00M	197.00M	167.60M	131.40M	115.20M
Research & Development	953.00M	838.00M	967.00M	997.00M	1.01B	1.21B	1.85B	2.11B	1.52B	1.49B	1.43B	1.36B	1.09B	933.00M	802.00M	786.00M	581.00M	495.00M	368.90M	338.40M	213.50M	165.00M	107.27M	104.58M	81.84M	68.10M	65.20M	62.80M	31.60M	36.60M
Other Operating Expenses	N/A	107.00M	98.00M	-4.00M	76.00M	291.00M	1.20B	636.00M	23.00M	-17.00M	-36.00M	40.00M	N/A	N/A	N/A	N/A	N/A	96.00M	54.30M	30.00M	-100.00M	N/A	N/A	N/A	68.42M	58.70M	52.00M	43.70M	25.40M	23.50M
Operating Income	433.00M	2.80B	3.20B	3.05B	2.80B	-1.64B	-17.48B	2.15B	3.35B	3.95B	1.65B	2.21B	3.11B	3.87B	2.40B	1.15B	2.40B	801.00M	1.31B	577.80M	877.40M	524.00M	360.79M	244.53M	199.05M	145.00M	173.80M	129.30M	115.20M	106.70M
Other Expenses / Income	-1.06B	-1.06B	-1.06B	-834.00M	-822.00M	-959.00M	-895.00M	-1.33B	-1.00B	-313.00M	-399.00M	-386.00M	-153.00M	-225.00M	-202.00M	-318.00M	-42.00M	-95.00M	-3.90M	-588.27M	-5.00M	-24.60M	-18.93M	-36.54M	-36.88M	-45.28M	-33.60M	-35.00M	-7.50M	-4.90M
Before Tax Income	-624.00M	-3.06B	658.00M	-4.41B	-1.26B	-2.60B	-18.38B	824.00M	2.35B	3.64B	1.25B	1.82B	2.96B	3.65B	2.20B	827.00M	2.35B	706.00M	1.31B	603.70M	872.40M	499.40M	341.86M	207.99M	162.17M	99.70M	140.20M	94.30M	107.70M	98.60M
Income Tax Expenses	-7.00M	-638.00M	211.00M	-168.00M	-278.00M	-195.00M	-1.93B	521.00M	634.00M	591.00M	-43.00M	-137.00M	127.00M	283.00M	166.00M	185.00M	397.00M	155.00M	236.20M	267.20M	181.50M	84.80M	63.65M	59.57M	44.34M	30.90M	38.70M	20.90M	27.90M	27.00M
Net Income	-559.00M	-2.35B	417.00M	-3.99B	-999.00M	-2.15B	-16.27B	329.00M	1.59B	3.06B	1.27B	1.96B	2.76B	3.33B	2.00B	635.00M	1.95B	546.00M	1.07B	331.80M	691.00M	410.30M	278.21M	148.42M	117.83M	68.80M	101.50M	73.40M	79.80M	71.60M
Interest Expenses	N/A	966.00M	1.06B	963.00M	822.00M	881.00M	895.00M	1.33B	1.00B	276.00M	282.00M	N/A	153.00M	225.00M	230.00M	318.00M	N/A	2.70B	4.40M	1.20B	N/A	16.80M	43.13M	193.07M	44.35M	67.30M	42.90M	46.00M	7.40M	5.10M
Basic Shares Outstanding	1.12B	1.11B	1.10B	1.09B	1.09B	1.02B	1.02B	955.00M	855.00M	853.00M	849.00M	872.00M	890.00M	896.00M	872.00M	780.00M	768.00M	756.00M	618.00M	612.70M	536.80M	529.00M	529.93M	516.23M	491.70M	488.30M	489.16M	489.33M	484.83M	482.86M
Diluted Shares Outstanding	1.12B	1.11B	1.11B	1.09B	1.09B	1.02B	1.02B	961.00M	864.00M	858.00M	850.00M	873.00M	893.00M	921.00M	896.00M	820.00M	830.00M	805.00M	681.00M	688.00M	590.00M	561.60M	545.51M	520.76M	491.70M	488.30M	489.16M	489.33M	484.83M	482.86M
EBITDA	1.57B	-874.00M	4.41B	-2.09B	1.28B	186.00M	-15.52B	2.87B	6.34B	5.97B	3.21B	3.88B	4.26B	4.83B	2.40B	1.15B	2.40B	2.53B	1.55B	1.39B	1.01B	524.00M	485.58M	470.19M	335.89M	262.48M	225.80M	173.00M	137.20M	134.30M
EBITDA Margin	9.91%	-5.86%	27.77%	-12.57%	7.57%	0.99%	-69.31%	13.08%	32.27%	29.47%	15.78%	19.11%	23.26%	29.93%	17.30%	10.33%	25.46%	30.05%	29.62%	29.03%	30.90%	20.81%	23.37%	26.87%	26.19%	23.52%	20.22%	18.14%	20.55%	22.85%
EBIT	-566.00M	-2.02B	1.69B	-3.19B	-455.00M	-1.46B	-17.30B	2.18B	3.22B	3.92B	1.51B	1.83B	3.04B	3.84B	2.40B	1.14B	2.35B	3.40B	1.31B	1.80B	872.50M	511.90M	384.99M	401.06M	206.51M	167.00M	183.10M	140.30M	115.10M	103.70M
EBIT Margin	-3.57%	-13.57%	10.62%	-19.18%	-2.69%	-7.76%	-77.30%	9.95%	16.40%	19.35%	7.42%	8.99%	16.60%	23.81%	17.24%	10.27%	24.97%	40.47%	25.01%	37.53%	26.63%	20.32%	18.53%	22.92%	16.10%	14.97%	16.39%	14.71%	17.24%	17.65%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31